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Summary
The mechanisms that mediate the recruitment of Th1
and Th2 lymphocytes in vivo are poorly understood.
We demonstrate that the mechanisms by which exog-
enously produced CD4+ Th1 and Th2 cells roll and ad-
here in Con A-inflamed liver microcirculation differ
dramatically: Th1 cells use 41-integrin and Th2 cells
use the vascular adhesion protein (VAP)-1. P-selectin
plays no detectable role in Th1 or Th2 cell trafficking
in liver microcirculation. Cellular recruitment in the
liver sinusoids has previously been shown to be inde-
pendent of many known adhesion molecules, leading
to the suggestion that recruitment in these structures
is mediated by physical trapping. While this may still
be true for neutrophils, Th1 and Th2 cells use 4-inte-
grin and VAP-1, respectively, to adhere within the
liver sinusoids.
Introduction
The classic paradigm for leukocyte recruitment states
that selectins are essential mediators of the initial teth-
ering and rolling of leukocytes in the microvasculature.
As the leukocytes roll along the microvasculature,
chemokines on the endothelium activate leukocyte in-
tegrins, causing the leukocytes to adhere to the endo-
thelium and subsequently emigrate from the vascula-
ture. This unifying theme was originally derived from
the results of in vitro flow chamber experiments that
primarily involved the perfusion of neutrophils over cy-
tokine (primarily TNFα)-stimulated human umbilical vein
endothelium (HUVEC) (Lawrence and Springer, 1991;
Macconi et al., 1995). Later studies, however, showed
that this paradigm was not universal. For example, per-
fusion of lymphocytes over IL-4-stimulated HUVEC re-
vealed that, like the selectins, α4-integrin can mediate
lymphocyte tethering and rolling (Alon et al., 1995). Much*Correspondence: pkubes@ucalgary.caof this in vitro data was supported by in vivo studies in
the microvasculature of the cremaster muscle and skin
(Hickey et al., 1999; Gonzalez et al., 2001). With the de-
velopment of methodology to visualize other microvas-
cular beds in vivo, it became clear that not all organs
follow the same paradigm under all conditions. For ex-
ample, in the liver, where the vasculature is extremely
complex, many of the aforementioned rules of recruit-
ment do not apply. Moreover, mechanisms of recruit-
ment for subsets of lymphocytes (e.g., Th1 and Th2
cells) that initiate many diseases have not been ex-
plored.
One unique feature of the liver is the presence of mul-
tiple compartments for leukocyte recruitment. The liver
has a dual blood supply in which venous blood from
the intestinal tract enters via the portal (presinusoidal)
venules and arterial blood enters via the hepatic arteri-
oles. These two blood supplies converge at the sinus-
oids, which drain the blood into the central (postsinu-
soidal) venules. Leukocyte recruitment has been shown
to occur in both the sinusoids and the postsinusoidal
venules. While the postsinusoidal venules show many
similarities to the postcapillary venules of cremasteric
muscle with respect to leukocyte recruitment (Wong et
al., 1997; Fox-Robichaud and Kubes, 2000), the sinus-
oids have many distinct recruitment characteristics. For
example, the sinusoidal endothelium is unique in that
it is discontinuous, lacks tight junctions, and does not
express typical endothelial adhesion molecules such as
PECAM-1, CD34, VE-cadherin, P-selectin, or E-selectin
(Lalor et al., 2002; Steinhoff et al., 1993; Scoazec and
Feldmann, 1994). Furthermore, blocking conventional
adhesion molecules, including selectins and integrins,
does not inhibit neutrophil recruitment (Fox-Robichaud
and Kubes, 2000; Wong et al., 1997; Jaeschke et al.,
1996) or lymphocyte adhesion (Hamann et al., 2000)
within the sinusoids of the inflamed liver. Based on
these observations and on the fact that the sinusoids
are tortuous, narrow conduits, it has been proposed
that leukocyte recruitment in these structures is medi-
ated by physical trapping rather than adhesive forces.
This contention is a default position that would change
if an adhesion molecule that is involved in leukocyte
recruitment in the sinusoids could be identified.
In humans, sinusoids have been shown to constitu-
tively express the novel adhesion molecule, vascular
adhesion protein (VAP)-1, which is upregulated during
an immune response (Scoazec and Feldmann, 1994;
McNab et al., 1996). VAP-1 is a 170 kDa homodimeric
glycoprotein that is expressed by endothelial cells and
that mediates lymphocyte binding to high endothelial
venules under shear conditions but also functions as an
amine oxidase potentially producing biologically active
oxidants. In addition to its expression in the liver, VAP-1
is known to be upregulated by chronic inflammation in
the vessels of the tonsil, gut, and synovium (Salmi and
Jalkanen, 1992; Salmi et al., 1993, 1997). Interestingly,
patients with liver disease have increased serum levels
of soluble VAP-1, although serum levels of VAP-1 are
unchanged in patients with rheumatoid arthritis or in-
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154flammatory bowel disease (Kurkijarvi et al., 2000) To
date, researchers have been unable to define the role
of VAP-1 in adhesion during an immune response, as
commonly used tissues such as the skin do not express
VAP-1, and murine reagents to inhibit VAP-1 have
been lacking.
We used a combination of recently developed anti-
mouse VAP-1 blocking antibodies (which affect adhe-
sion and not enzymatic activity), intravital microscopy
of the multicompartmented microvasculature of the
liver, and in vitro differentiated Th1 and Th2 cells to in-
vestigate the mechanisms by which these leukocyte
subsets roll and adhere in Con A-mediated liver inflam-
mation.
Results
VAP-1 Antibodies Do Not Inhibit
the Enzymatic Activity
The specificity of three antibodies (7-88, 7-106, 7-188)
to bind mouse VAP-1 has previously been demon-
strated by staining stably tranfected CHO cells ex-
pressing mouse VAP-1 and further fully characterized
elsewhere (Merinen et al., 2005).
Since VAP-1 has both adhesion-dependent and en-
zyme-dependent functions, and the latter could affect
the former, we determined whether the anti-mouse
VAP-1 mAbs (7-88, 7-106, 7-188) would interfere with
the enzymatic activity of VAP-1. When transfectants
stably expressing mouse VAP-1 were pretreated with
anti-VAP-1 mAbs, the enzyme activity (H2O2 produc-
tion) was not affected when compared to two different
control mAb (H-1, 8-18) treatments (Figure 1A). A semi-
carbazide enzyme inhibitor completely abolished enzy-
matic activity (data not shown). Moreover, none of the
three anti-VAP-1 mAbs alone or in tandem blocked sig-
nificantly the enzymatic activity of VAP-1 in mice (Fig-
ure 1B). With respect to adhesion, a previous report,
as well as our own preliminary intravital experiments,
determined that 7-106 contains 80% of the total activity
but that all three antibodies are required for maximal
inhibition of VAP-1-mediated events (data not shown;
Merinen et al., 2005).
Expression of VAP-1 by Hepatic Venules
and Sinusoids Is Upregulated
during Con A-Mediated Inflammation
As previously described for human liver, we observed
constitutive expression of VAP-1 in liver venules of con-
trol mice versus a nonbinding control (Figure 2B versus
Figure 2A). In the Con A-induced liver inflammation, si-
nusoidal endothelial cells lacked or had only a diffuse
VAP-1 reactivity, whereas the hepatic veins displayed
more endothelial positivity when compared to untreated
controls (Figures 2C and 2B, respectively). Interestingly,
central and portal veins stained more strongly for
VAP-1 when compared to hepatic venules (Figure 2D).
To confirm the increase of VAP-1 during inflammation, we
scored the staining intensity of VAP-1 on liver vessels in
a blinded fashion using a staining scale (Bono et al.,
1999). This scoring showed that Con A significantly in-
creased (1) the number of vessels that stained positive
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higure 1. Anti-VAP-1 mAbs Do Not Interfere with the Enzymatic
ctivity of VAP-1
A) CHO cells stably expressing VAP-1 were pretreated with the
ndicated concentrations of control (Hermes-1 [H-1] and TK8-18)
nd anti-mouse VAP-1 (7-88, 7-106, and 7-188) mAbs, and the VAP-1
ependent formation of hydrogen peroxide was determined. The
ata are mean ± SD from four independent assays (each treatment
as done in duplicate in each assay) as compared to the H2O2
ormation in the absence of antibodies (No).
B) Anti-VAP-1 mAbs as a pool or separately and control mAb were
dministered intravenously to mice, and the VAP-1 enzyme activity
n serum was determined using the radiochemical assay. The data
re mean ± SD. Note that semicarbazide (an VAP-1 enzyme inhibi-
or) completely abolishes the enzyme activity of VAP-1 in these as-
ays (by definition).or VAP-1; (2) the staining intensity of the vessels; and
3) the extension of VAP-1 from the vessel wall (Figure 2E).
xpression of VCAM-1, MAdCAM-1, and P-Selectin
n Con A-Mediated Liver Inflammation
CAM-1 was expressed within the portal as well as
ostsinusoidal venules and prominently expressed on
inusoids following Con A administration (Figures 3A
nd 3B, with long and short arrows identifying portal
enule and sinusoids, respectively). The other α4-integ-
in ligand, MAdCAM-1, was not detectable in the portal
enules, and very little or no increase in the postsinu-
oidal venules and sinusoids was observed following
on A administration (Figures 3C and 3D). Because of
he difficulty associated with immunohistochemistry
ith P-selectin, we used the dual-radiolabeling tech-
ique to measure the expression of P-selectin in control
nd Con A-treated mice and compared it to VCAM-1.
-selectin could not be detected in the livers of control
ice; however, it was present in the livers of mice that
ad been treated with Con A for 4 hr (Figure 3E). Nota-
ly, in this animal model of liver inflammation we ob-
erved that induction of P-selectin expression was
ighest in the liver. For comparison, Figure 3E also
CD4+ T Cell Recruitment
155Figure 2. VAP-1 Expression by the Liver Is
Upregulated during Inflammation
BALB/c mice were left untreated or were
treated with Con A for 4 hr. Immunhisto-
chemistry of liver sections from untreated
mice using secondary antibody alone (no
primary antibody) is shown as a negative
control (A). Hepatic venules in untreated
mice exhibit constitutive VAP-1 expression
(B), which is dramatically increased in Con
A-treated mice (C). In (D), portal and central
veins show higher levels of VAP-1 expres-
sion than hepatic venules. VAP-1 staining
within each vessel was qualitatively as-
signed to a category ranging from 0 (no
staining) to 3 (greatest staining). The percent
of vessels in each category from liver sec-
tions from control or Con A-treated mice was
then quantified (E). Results are expressed as
the mean ± SEM of the percent of vessels
visualized from three mice per group. *p <
0.05 compared to control.shows P-selectin in the small bowel (the second high-
est P-selectin expression), demonstrating that Con A
clearly targets the liver in a very significant manner.
VCAM-1 was expressed in control mice and was in-
creased more than 3-fold following exposure to Con A
(Figure 3F), to similar levels as P-selectin. VCAM-1 ex-
pression in Con A-treated mice was significantly less in
other organs such as the small bowel (Figure 3F).
4-Integrin and VAP-1 Mediate Th1 and Th2 Rolling,
Respectively, in the Postsinusoidal Venules
Figure 4 exemplifies intravital microscopy images visu-
alized with both Th1 and Th2 cells localizing in the
postsinusoidal venules (Figure 4A) as well as sinusoids
(Figure 4B) during inflammation. Quantification of the
data suggests that very few of the injected Th1 cells
rolled in the postsinusoidal venules of control mice,
while a significant increase in Th1 rolling flux in the
postsinusoidal venules of Con A-treated mice resulted
(Figure 4C). The administration of either an anti-P-
selectin mAb or anti-VAP-1 mAbs had no effect on Th1
cell rolling in the postsinusoidal venules (Figure 4D),
suggesting that this is a P-selectin- and VAP-1-inde-
pendent process. In contrast, the administration of an
anti-α4-integrin mAb significantly reduced the rolling
flux of Th1 lymphocytes by approximately 70% (Figure
4D). The exclusive role of α -integrin in rolling interac-4tions of Th1 cells on endothelial cells in the postsinu-
soidal venules is surprising given that Th1 cell traffick-
ing in the skin has been shown to be entirely P-selectin
dependent (Borges et al., 1997).
In a similar set of experiments, in control mice, few if
any Th2 cells rolled in the postsinusoidal venules. In
mice treated with Con A for 4 hr, there was a significant
increase in Th2 cell rolling flux (Figure 4E). Neither an
anti-P-selectin mAb nor an anti-α4-integrin mAb re-
duced Th2 cell rolling flux (Figure 4F). Strikingly, anti-
VAP-1 mAbs reduced Th2 cell rolling flux by 75% (Fig-
ure 4F).
Th1 and Th2 Cell Adhesion in Sinusoids Is Mediated
by Specific Adhesion Molecules
To date, no tested antiadhesion treatment has reduced
leukocyte recruitment within the sinusoids, leading in-
vestigators to propose that cells are recruited to this
compartment by physical trapping. Interestingly, when
we examined Th1 and Th2 cell recruitment to the sinu-
soids of Con A-treated mice, we found that (1) it com-
prised primarily of adhesion not rolling and (2) the ad-
hesion of both cell types was governed by specific
adhesion molecules. Th1 cell adhesion in the sinusoids
was blocked by an anti-α4-integrin mAb, while Th2 cell
adhesion in the sinusoids was blocked by anti-VAP-1
mAbs (Figure 5A). Each adhesion molecule was spe-
Immunity
156Figure 3. Increased P-Selectin and VCAM-1
Expression in the Inflamed Liver
Immunhistochemistry of liver sections from
untreated and Con A treated mice to visual-
ize VCAM-1 (A and B) as well as MAdCAM-1
(C and D). Radiolabeled anti-P-selectin mAb
(E) or anti-VCAM-1 mAb (F) was adminis-
tered to untreated BALB/c mice (control) or
BALB/c mice treated with Con A (Con A),
and expression of adhesion molecule ex-
pression was measured in all tissues. Pre-
sented are data in liver and for comparison
in small bowel. Data are expressed as the
arithmetic mean ± SEM of four animals per
group. *p < 0.05 relative to control.cific for only one type of T cell, as Th1 cell adhesion
was unaffected by anti-VAP-1 mAbs, and Th2 cell adhe-
sion was unaffected by an anti-α4-integrin mAb (Figure
5A). To our knowledge, these results provide the first
positive antiadhesion data in sinusoids in vivo during
inflammation.
Also shown in Figure 5A, blocking VCAM-1, but not
MAdCAM-1, significantly inhibited Th1 lymphocyte ad-
hesion, thereby implicating the α4β1 integrin, and not
α4β7, in the initial interactions of Th1 cells with the he-
patic vasculature. These results are also supported by
our immunohistochemistry data in which we observed
a profound increase in VCAM-1, but not MAdCAM-1,
staining on the postsinusoidal and sinusoidal venules
of livers from Con A-treated mice (Figure 3).
Th1 and Th2 Cell Adhesion in Postsinusoidal
Venules Uses Similar Adhesive Mechanisms
as in Sinusoids
Figure 5B demonstrates that Th2 lymphocyte adhesion
in the postsinusoidal venules was also reduced by 70%
by an anti-VAP-1 mAb but not with an anti-α4-integrin
antibody. There was only a very subtle increase in Th1
cell adhesion in postsinusoidal vessels, and Ab to VAP-1
had no effect upon Th1 localization within this compart-
ment. The Th1 adhesion in the postsinusoidal venules
was blocked significantly by an antibody to VCAM-1
(Figure 5B). Although α -integrin antibody had a small
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each significance (Figure 5B), presumably due to the
ow number of adhering Th1 cells in this compartment.
on A-Induced Endogenous CD4+ T Lymphocyte
ecruitment into Liver Is also VAP-1
nd 4-Integrin Dependent
o compare ex vivo polarized CD4+ lymphocyte beha-
ior to endogenously recruited CD4+ T lymphocytes,
mmunohistochemistry was performed. Quantification
f cells staining positively for CD4 in 20 fields of view
er liver section revealed a small but significant, 3-fold
ncrease in CD4+ T cell recruitment following Con A
reatment (Figures 6A–6C), and this increase was par-
ially reduced when the mice were pretreated with an
ntibody to VAP-1 (Figure 6C). Blocking α4-integrin also
nhibited endogenous T cell recruitment (Figure 6C).
dditionally, a detectable increase in the Th1-type cy-
okine IFNγ (Figure 6D) and Th2-type cytokine IL-4 (Fig-
re 6E) were noted in Con A-mediated liver inflam-
ation, and their production was significantly reduced
n mice pretreated with antibodies to α4-integrin and
AP-1, respectively.
It should be noted that to visualize the inflamed liver
icrovasculature it was necessary to use low levels of
onA (avoiding very sluggish blood flow and edema).
his resulted in a small degree of lymphocyte recruit-
ent (see above, Figure 6) and a very subtle increase
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157Figure 4. α4β1-Integrin Mediates Th1 Lym-
phocyte Rolling While VAP-1 Mediates Th2
Lymphocyte Rolling in the Inflamed Liver
(A and B) Visualized by intravital microscopy,
Con A treatment increases exogenously ad-
ministered lymphocyte rolling and adhesion
in the postsinusoidal venules (A) as well as
sinusoids (B). The arrows point to rolling or
adherent Th2 lymphocytes.
(C) Th1 cell rolling flux in the postsinusoidal
venules of the liver of control and Con
A-treated mice was determined.
(D) After the basal levels of Th1 cell rolling
flux were recorded in Con A-treated mice,
isotype controls (cont Ab) or blocking anti-
bodies against P-selectin, α4-integrin, or
VAP-1 were administered.
(E) Th2 cell rolling flux in the postsinusoidal
venules of the livers of control and Con
A-treated mice.
(F) After the basal levels of Th2 cell rolling
flux were recorded in Con A-treated mice,
isotype controls (cont Ab) or blocking anti-
bodies were administered.
All data are expressed as the arithmetic
mean ± SEM of the percentage of Th1 or Th2
cell rolling flux of at least three animals per
group. *p < 0.05 relative to control animals
(C and E) or isotype control Ab-treated mice
(D and F).in liver damage (ALT levels) at 8 hr, but not 4 hr, post
Con A administration (untreated 133 ± 7 IU/ml versus
Con A 179 ± 18 IU/ml). The small increase in liver en-
zymes was entirely abrogated with VAP-1 antibody
(136 ± 12 IU/ml) but not with α4-integrin antibody.
Neutrophil Rolling, but Not Adhesion, during Con
A-Induced Hepatitis Is Mediated by VAP-1
Previous studies have demonstrated that lymphocyte
recruitment is preceded and dependent upon neutro-
phil recruitment. Moreover, we have previously shown
that more than 90% of the endogenous rolling cells in
the livers of Con A-treated mice are neutrophils (Bonder
et al., 2004). Very few neutrophils rolled along the
postsinusoidal venules of control mice, whereas the
rolling flux of neutrophils was significantly increased af-
ter 4 hr of Con A treatment (Figure 7A). Unlike either Th1
or Th2 lymphocytes, a blocking antibody to P-selectin
reduced neutrophil rolling flux in Con A-treated mice by
40% (Figure 7B). We observed no reduction in rolling
flux when α4-integrin was blocked (Figure 7B). Clearly,
the majority of neutrophil:endothelial cell interactions in
the postsinusoidal venules of Con A-treated mice are
independent of both P-selectin and α4-integrin. This is
noteworthy, as 90%–100% of neutrophil rolling is
P-selectin-dependent in the cremaster and mesentery(Wong et al., 1997). As shown in Figure 7B, approxi-
mately 90% of the neutrophil rolling was inhibited by
anti-VAP-1 antibodies. Notably, the same anti-VAP-1
antibodies had no effect on neutrophil:endothelial cell
interactions in other tissues such as the cremaster
muscle (data not shown).
Prolonged (45–60 min) exposure to anti-VAP-1 mAbs
had no effect on neutrophil adhesion in either the
postsinusoidal venules or sinusoids (data not shown).
These results suggest that in the few rolling cells, adhe-
sion is highly efficient in this model, given that 90% of
neutrophil rolling is attenuated following exposure to
anti-VAP-1 mAbs. The shear in postsinusoidal vessels
was less than 50% (100–200 s−1) of that seen in post-
capillary venules of commonly studied tissues (using
fluorescent beads to estimate velocities), consistent
with the view that adhesion occurs extremely effec-
tively in low-shear vessels regardless of amount of roll-
ing cells. Anti-P-selectin mAb and anti-α4-integrin mAb,
either alone or together, did not attenuate neutrophil
adhesion.
A similar role for VAP-1 in neutrophil recruitment was
seen in a second model of liver inflammation. Admin-
istration of TNFα elicited a significant increase in neu-
trophil rolling in postsinusoidal venules after 4 hr (Fig-
ure 7C). Blocking VAP-1 reduced neutrophil rolling flux
Immunity
158Figure 5. Effects of Prolonged Exposure to Anti-VAP-1 mAbs or
Anti-α4-Integrin mAb on Th1 and Th2 Cell Adhesion
Th1 and Th2 cell adhesion in the sinusoids following 45–60 min
exposure to antibodies against VAP-1, α4-integrin, VCAM-1, or
MAdCAM-1 with lymphocyte adhesion calculated per field of view
(fov) (A) in sinusoids and (B) in the postsinusoidal venules. Data are
expressed as the arithmetic mean ± SEM of at least four animals
per group. *p < 0.05 relative to Con A treatment alone.
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Min the postsinusoidal venules of TNFα-treated mice by
approximately 70% (Figure 7C) but did not affect neu-
trophil adhesion (data not shown). Prolonged exposure
to anti-VAP-1 mAbs was similarly unable to attenuate
neutrophil adhesion in the liver of TNFα-treated mice
(data not shown). Even when anti-VAP-1 mAbs were
administered prior to Con A or TNFα treatment, the
cocktail of mAbs had no effect on leukocyte adhesion
in either the postsinusoidal venules (Figure 7D) or si-
nusoids (data not shown). Furthermore, quantification
of neutrophil esterase staining in 20 fields of view per
liver section revealed a 5-fold increase in neutrophil ad-
hesion following Con A or TNFα treatment and that ad-
ministration of antibodies to VAP-1 did not inhibit their
recruitment (Figure 7E). These data strongly support
the conclusion that VAP-1 mediates neutrophil rolling
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wbut not adhesion in Con A-mediated inflammation.iscussion
hereas Th1 lymphocytes have been described to traf-
ic to inflamed skin and retina via P-selectin, the mech-
nisms by which Th2 cells traffic have not been fully
lucidated (Austrup et al., 1997; Xu et al., 2004). In this
tudy, we report that ex vivo polarized Th1 and Th2 lym-
hocytes use distinct recruitment mechanisms within
on A-mediated inflammation. Neither of these mecha-
isms involves P-selectin, despite the fact that P-selec-
in is significantly upregulated in the inflamed liver. Th1
ells use α4-integrin to traffic in postsinusoidal venules,
hereas Th2 cells exclusively use VAP-1. We also re-
ort for the very first time that these same adhesive
echanisms are important for Th1 and Th2 cell adhe-
ion in the liver sinusoids. Previous in vitro studies sug-
est that the enzymatic function of VAP-1 markedly
ontributes to the rolling and transmigration phase of
eukocytes (Jaakkola et al., 2000). Moreover, Merrinen
nd colleagues have recently shown that adhesive and
nzymatic activities of VAP-1 take place in sequence
nd may thus be part of the same cascade (Merinen et
l., 2005). Our own data suggest that these antibodies
o VAP-1 do not inhibit the enzymatic activity of VAP-1
nd hence they function by blocking the adhesive epi-
ope(s) of VAP-1.
Leukocyte recruitment in the liver occurs in both si-
usoids and postsinusoidal venules. In the postsinusoi-
al venules, the classic paradigm of selectin-depen-
ent rolling and integrin-dependent adhesion occurs to
ome extent in response to chemokines and bacterial
roducts such as LPS (Wong et al., 1997). Leukocyte
ecruitment in the sinusoids appears to occur by quite
ifferent mechanisms, as neither selectins nor integrins
ppear to be involved in leukocyte recruitment in these
tructures (Wong et al., 1997). Coupled with the sinus-
ids’ characteristic low shear, narrow tortuous architec-
ure, and limited adhesion molecule expression, this
as led to the proposal, albeit by default, that leukocyte
ecruitment in the sinusoids is mediated by physical
rapping rather than by adhesive mechanisms. Factors
uch as vasoconstriction, endothelial swelling and in-
ury, and reduced membrane flexibility in activated leu-
ocytes have been considered as further evidence in
upport of mechanical trapping of neutrophils and lym-
hocytes within the sinusoids (Jaeschke et al., 1996;
cCuskey et al., 1996; Hamann et al., 2000). This study
hallenges this theory by demonstrating that both Th1
nd Th2 cells adhere within the sinusoids via adhesion
olecules. Specifically, adhesion in these structures is
ediated by α4β1-integrin (Th1 cells) and VAP-1 (Th2
ells). Interestingly, work by John and Crispe (2004) re-
ealed that CD8+ lymphocytes do use ICAM-1 and
CAM-1 to infiltrate the liver, but whether this occurs in
inusoids or pre- or postsinusoidal vessels remains to
e elucidated.
To our knowledge, all studies to date have implicated
-selectin as the principle mediator of Th1 cell rolling
nd subsequent adhesion within the inflamed vascula-
ure (Austrup et al., 1997; Xu et al., 2004). Our current
tudy shows that this is not a universal mechanism for
h1 cell recruitment, as P-selectin was not involved in
h1 cell rolling in Con A-mediated inflammation. This
as despite our observations that P-selectin is upregu-lated in the inflamed hepatic endothelium and that our
CD4+ T Cell Recruitment
159Figure 6. Con A-Induced Recruitement of
In Vivo CD4+ Lymphocytes as Well as IFNγ
and IL-4 Production in the Livers of Mice
(A and B) Immunohistochemistry of liver sec-
tions from untreated mice (A) shows basal
numbers of CD4+ lymphocytes (arrow). In-
creased CD4+ lymphocytes are seen in 4 hr
Con A-treated mice ([B], arrows).
(C) Quantitative analysis of CD4+ lymphocyte
recruitment into the liver in untreated and
Con A mice ± VAP-1 or α4-integrin antibodies.
(D and E) For IFNγ (D) and IL-4 (E) produc-
tion, mice were untreated or treated with
Con A ± VAP-1 Ab or α4-integrin Ab, and cy-
tokine levels were assessed by ELISA. Data
are expressed as the arithmetic mean ± SEM
of at least four animals per group. *p < 0.05
relative to controls and #p < 0.05 relative to
Con A alone.in vitro-differentiated Th1 cells can bind to P-selectin
(data not shown). In this microenviroment, it is the α4β1-
integrin alone which mediates Th1 lymphocyte rolling
in the postsinusoidal venules. Therefore, despite the
expression of functional P-selectin (neutrophils used
this molecule) on liver postsinusoidal endothelium, Th1
cells preferentially used VCAM-1 in this microenviron-
ment. It is our contention that the lower shears ob-
served in the liver microvasculature would enhance
VCAM-1 interactions while decreasing the likelihood of
P-selectin interactions. Indeed, we have previously
shown that, at lower shear rates, VCAM-1 supports
optimal leukocyte rolling, whereas the efficiency of
P-selectin is dramatically reduced at these same lower
shear rates (Reinhardt et al., 1997). Since the shear
rates in the liver microcirculation were less than 50%
of that seen in the vasculature of other tissues, VCAM-1
interactions would be favored. This also demonstrates
a physiological importance for the differential efficiency
of VCAM-1 and selectins at different shear rates.
Our inability to block Th2 cell rolling in the inflamed
liver with antibodies against either selectins or integrins
is entirely in line with a potentially novel mechanism for
interactions between Th2 cells and endothelial cells. In
this study, we observed that VAP-1, a molecule that
has, to our knowlege, never before been described to
mediate the recruitment of CD4+ T cells, selectivelysupported Th2, but not Th1, cell rolling in the postsinu-
soidal venules of the inflamed liver. Although CD4+ T
cells have been reported to not bind VAP-1 in vitro, this
study differs from our current study, as the CD4+ T cells
were not polarized to a Th2 phenotype in the previous
study (Salmi et al., 1997). Moreover, we demonstrate
that blocking VAP-1 attenuated endogenous CD4+ T
cell recruitment within the liver of Con A-treated ani-
mals. Furthermore, our study suggests that VAP-1 also
mediates Th2 cell adhesion in both the postsinusoidal
venules and the hepatic sinusoids. These results are
further supported by an increase in VAP-1 expression
in both the postsinusoidal venules and the sinusoids
during Con A-mediated inflammation. The highest de-
gree of VAP-1 expression was in the portal vessels.
These venules are frequently oriented perpendicular to
the field of view and are therefore extremely difficult to
visualize. Interestingly, when we could examine small
visible sections of these vessels, they were intensely
fluorescent. Although individual fluorescent Th2 cells
could not be discerned and quantified, presumably
they are binding in these regions. This was further
borne out using immunohistochemistry for endogenous
CD4+ T cells; these lymphocytes were seen binding to
and surrounding the portal vessels.
Interestingly, in contrast to other tissues, only a minor
role for P-selectin was detected for neutrophil rolling in
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160Figure 7. VAP-1 and P-Selectin Mediate Neu-
trophil Rolling Flux, but Not Adhesion, in the
Inflamed Liver
(A) Neutrophil rolling flux in control and Con
A-treated mice was determined.
(B) After basal levels of rolling flux were re-
corded in Con A-treated mice, isotype con-
trols (cont Ab) or blocking antibodies against
P-selectin, α4-integrin, or VAP-1 were admin-
istered.
(C) The rolling flux of neutrophils in the
postsinusoidal venules of untreated and
TNFα-treated mice, without or with admin-
istration of anti-VAP-1 antibodies, was deter-
mined.
(D) Adhesion of neutrophils in the postsinu-
soidal venules of mice, with or without pre-
treatment of antibodies against VAP-1 ±
P-selectin.
(E) The localization of neutrophils within the
sinusoids of the mice from (D) was deter-
mined using Leder (esterase) staining of
liver sections.
Data are expressed as the number of ester-
ase-positive cells in 20 high-power fields
(hpf) of view, and all results are expressed as
the arithmetic mean ± SEM of at least three
mice per group. *p < 0.05 relative to controls
and #p < 0.05 relative to Con A or TNFα
alone.the postsinusoidal venules. These results support the
work of Massaguer and colleagues who recently dem-
onstrated that P-selectin-deficient mice exhibit only a
slight, albeit significant, reduction in leukocyte rolling
within the inflamed liver vasculature (Massaguer et al.,
2002). In this study, we found that VAP-1 was the prin-
ciple mediator of neutrophil rolling during Con A-medi-
ated inflammation. Interestingly, VAP-1 was not involved
in neutrophil adhesion within either the postsinusoidal
venules or the sinusoids. Addition of blocking antibod-
ies to VAP-1 plus P-selectin (as well as VAP-1/P-selec-
tin/ICAM-1; data not shown) exhibited no attenuation
of neutrophil adhesion in these compartments. At first
glance, the observation that neutrophil adhesion can-
not be prevented by blocking VAP-1 despite the fact
that neutrophil rolling was blocked by 90% seems at
odds with the notion that rolling begets adhesion. In
fact, the observation is entirely in line with a previous
publication wherein we demonstrated that leukocyte
rolling needed to be inhibited by at least 90% to be
effective at inhibiting adhesion by only 50%. Moreover,
the inhibition of adhesion as a result of reduced rolling
was seen only in higher shear vessels. In fact 90% inhi-
bition of rolling in lower shear vessels still had abso-
lutely no impact on adhesion (Kubes et al., 1995). Since
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rhe liver vessels are already in a state of low shear
measured herein as 100–200 s−1), it is not surprising
hat very little rolling begets normal adhesion.
imitations and Conclusions
ne important potential limitation of our study relates
o the recently observed difference between ex vivo
olarized CD4+ lymphocytes and endogenously polar-
zed CD4+ lymphocytes (Campbell and Butcher, 2002;
retschmer et al., 2004). Although the evidence would
uggest that CD4+ Th1 lymphocytes use similar recruit-
ent mechanisms regardless of whether they were de-
ived ex vivo or whether they were studied in vivo, CD4+
h2 lymphocytes do display different molecular mecha-
isms of recruitment depending on ex vivo or in vivo
rigin. While ex vivo CD4+ Th2 lymphocytes were
hown not to bind selectins or express mature selectin
igands, endogenous CD4+ Th2 lymphocytes traffic to
kin and other organs via selectins (Campbell and
utcher, 2002; Kretschmer et al., 2004). However, our
x vivo CD4+ Th2 lymphocytes, unlike those previously
sed, do in fact express selectin ligands and bind and
oll on selectins very effectively (C.S.B. and P.K., un-
ublished data). This was achieved by using two
ounds of cytokine exposure for 2 weeks (see Experi-
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161mental Procedures). Moreover, a small proportion of
endogenous CD4+ lymphocytes homed to liver at least
in part by VAP-1, consistent with our ex vivo Th2 data.
Finally, we also demonstrated that anti-VAP-1 therapy
blocked both CD4+ lymphocyte recruitment as well as
the increase in IL-4. However, it should be noted that it
is not possible to attribute all of the elevated IL-4 levels
to infiltrating CD4+ Th2 lymphocytes. In fact, there is
good evidence that some of the elevated IL-4 is related
to NKT cells (Kaneko et al., 2000), and whether the
VAP-1 antibody was targeting Th2 as well as NKT cells
remains to be determined. Similarly, the reduced liver
enzyme levels with anti-VAP-1 could reflect inhibition
of Th2 and/or NKT cell-derived IL-4, a cytokine known
to contribute to the liver injury (Jaruga et al., 2003).
In conclusion, our data demonstrate that, even in the
tortuous, low-shear sinusoidal vessels of the liver, CD4+
lymphocyte recruitment requires adhesive mechanisms.
Moreover, this study suggests these mechanisms to be
α4β1-integrin for CD4+ Th1 cells and VAP-1 for the CD4+
Th2 cells. Although our study did not identify an adhe-
sive mechanism for neutrophils in the sinusoids, it does
renew our enthusiasm that neutrophil recruitment in the
sinusoids is mediated by a specific adhesion molecule.
Most importantly, a very significant number of leuko-
cytes are recruited into the sinusoids in many different
diseases ranging from sepsis to virally induced hepati-
tis and autoimmune liver diseases. Inhibiting the in-
appropriate recruitment of leukocytes into sinusoids
could improve the pathogenesis of a number of these
disease states. Indeed, our data that VAP-1 reduces
some of the liver inflammation is further underscored
by observations from human studies that liver sinu-
soids have increased VAP-1 expression during an im-
mune response (Scoazec and Feldmann, 1994; McNab
et al., 1996) as well as increased serum levels of soluble
VAP-1 in liver but not intestinal or joint disease (Kurki-
jarvi et al., 2000).
Experimental Procedures
Reagents and Mice
RB40.34 (anti-P-selectin), R1-2 (anti-α4 integrin), 11B11 (anti-IL-4),
XMG1.2 (anti-IFNγ), JES5-16E3 (anti-IL-10), and isotype control an-
tibodies were purchased from BD Biosciences (Mississauga, ON,
Canada). Antibodies to CD4, VCAM-1, MAdCAM-1, ICAM-1, and
their respective controls were purchased from R&D Systems (Min-
neapolis, MN). Rat anti-mouse antibodies to VAP-1 (7-88 [IgG2b],
7-106 [IgG], and 7-188 [IgG2b]) were generated and characterized
as reported elsewhere (Merinen et al., 2005). Concanavalin A was pur-
chased from Sigma-Aldrich (Oakville, ON, Canada). BALB/c (Charles
River Breeding Laboratories, Montreal, QC, Canada), DO11.10 mice
(gift from Dr. Casey Weaver, Birmingham, AL), and C57BL/6 mice
(Charles River Breeding Laboratories) were maintained in the viral
antigen-free double-barrier unit at the University of Calgary. Mice
were used between 6 and 10 weeks of age. All experimental pro-
cedures were approved by the Animal Care Committee of the Uni-
versity of Calgary and conformed to the guidelines established by
the Canadian Council for Animal Care.
Con A- or TNF-Induced Hepatic Injury
A sterile saline control or Con A (13 mg/kg) was administered i.v.
to BALB/c mice 4 hr before analysis. The dose and time period of
Con A used in these studies were slightly lower than those that
have been used previously to induce liver injury (20 mg/kg for 8 hr)
(Tiegs et al., 1992; Mizuhara et al., 1994). We chose this dose and
time period of Con A (13 mg/kg for 4 hr) to induce sufficient inflam-mation in the liver microvasculature to recruit different cell popu-
lations while leaving the mice healthy enough to withstand anes-
thesia, surgery, and prolonged intravital microscopy. In similar
experiments, TNFα (0.5 mg/kg) was injected i.p. into C57BL/6 mice
4 hr before analysis. Serum alanine aminotransferase (ALT), as an
index of hepatocellular injury, was determined from mice either left
untreated or treated with Con A (with or without anti-VAP-1 Abs)
for 8 hr prior to sacrifice as previously described (Bonder et al.,
2004). A commercially available ELISA kit was used to measure
tissue homogenate concentrations of IFNγ and IL-4 (Genzyme). Fi-
nal concentrations of IFNγ and IL-4 were corrected for concentra-
tions of protein in each homogenate sample and are represented
as picograms of cytokine/milligram of protein.
Lymphocyte Purification and Characterization
of OVA-Specific Th1 and Th2 Cells
CD4+ T cells were isolated from pooled spleens of DO11.10 mice
using mouse CD4 (L3T4) Dynabeads according to the manufactur-
er’s protocol (Dynal Biotech). The resulting CD4+-enriched cells
were stained with FITC-conjugated KJ1-26 (anti-DO11.10 TCR
[Haskins et al., 1983]) and PE-conjugated anti-CD4 and analyzed
by flow cytometry to determine the purity of the population where
isolated cells were routinely greater than 90% CD4+.
Th1 and Th2 cells were generated in vitro from these freshly iso-
lated, antigen-naive CD4+ T cells as previously described (Bucy et
al., 1995). Briefly, purified CD4+ T cells were cultured with 5 g/ml
OVA peptide 323–339 and with irradiated BALB/c splenocytes at a
T cell:splenocyte ratio of 1:5 (for Th1) or 1:25 (for Th2). Cells were
differentiated toward a Th1 phenotype using 50 U/ml IL-12 (R&D
Systems) and 10 g/ml anti–IL-4 (11B11 [Ohara and Paul, 1985]) or
toward a Th2 phenotype by including 1000 U/ml IL-4 (R&D Sys-
tems) and 10 g/ml anti–IL-12 (C17.8 [Wysocka et al., 1995]) (Szabo
et al., 1995). To generate a sufficiently polarized Th2 phenotype of
which the majority of cells produced IL-4, the cells were pushed a
second time, as above. Recovered cells were washed and transfer-
red on day 7 (for Th1) and day 14 (for Th2) at 107 cells/recipient
mouse.
To confirm that Th1 and Th2 cells had been generated, a sepa-
rate aliquot of 5 × 106 cells was stimulated for 6 hr with PMA (50
ng/ml; Sigma Chemical Co.) and ionomycin (750 ng/ml; Sigma
Chemical Co.) and analyzed for intracellular cytokine expression
using Cytofix/Cytoperm Plus with GolgiPlug Kit (BD BioSciences).
PE-conjugated anti-IL-4 (11B11, BD BioSciences), anti-IL-10 (JES5-
16E3, BD BioSciences), or anti-IFNγ (XMG1.2, BD BioSciences) as-
sessed cytokine production via a BD Biosciences FACScan (Moun-
tain View, CA). Intracellular cytokine staining showed that 75% ±
6% of the activated Th1 lymphocytes produced the Th1 cytokine
IFNγ, and less than 1% of these cells produced the Th2 cytokines
IL-4 and IL-10. In contrast, the majority of the stimulated Th2 lym-
phocytes produced IL-4 and less than 1% produced IFNγ (data
not shown).
Intravital Microscopy in the Liver
Murine liver intravital microscopy was performed as previously de-
scribed (Wong et al., 1997). Briefly, mice were anesthetized using
10 mg/kg xylazine and 200 mg/kg ketamine hydrochloride, the jug-
ular vein was cannulated for maintenance of anesthesia and subse-
quent cell injections. Postsinusoidal venules (25–40 m diameter)
and their associated sinusoids were selected randomly for each
study. Endogenous leukocytes were visualized by trans-illumina-
tion, while in vitro-differentiated T cells were labeled ex vivo (rhoda-
mine 6G at 25 g/107 cells [Sigma Chemical Co.] for 5 min RT then
washed) and visualized by epi-illumination. Images and cellular
trafficking were recorded and analyzed as previously described
(Bonder et al., 2004). Antibodies to P-selectin (20 g), α4-integrin
(70 g), VAP-1 (cocktail of 7-88, 7-106, and 7-188, 50 g each),
VCAM-1 (100 g), or MAdCAM-1 (200 g) were administered i.v. in
200 l sterile saline. In all cases, isotype-matched Abs were used
as negative controls.
Shear rates in postsinusoidal venules were initially measured by
using fluorescently labeled beads and counting their velocity frame
by frame. However since free-flowing fluorescently labeled lympho-
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162cytes moved at similar speeds as the beads, we measured veloci-
ties of the former as previously described (Hickey et al., 2002).
Quantification of P-Selectin and VCAM-1 Expression
P-selectin and VCAM-1 expression were determined as a measure
of endothelial activation using a modified dual-radiolabeled Ab
technique (Hickey et al., 1999). P-selectin expression was mea-
sured using the mAbs RB40.34 (anti-P-selectin) and A110-1 (rat
IgG1, λ isotype control), while VCAM-1 expression was measured
using the mAbs 5F10 (anti-VCAM-1) and P-32 (rat IgG2a, κ isotype
control). The anti-adhesion molecule mAbs were labeled with 125I,
and isotype controls were labeled with 131I using the Iodogen
method (Hickey et al., 1999).
To measure P-selectin expression, animals were injected i.v. with
a mixture of 10 g 125I-RB40.34 and 400,000–600,000 cpm of 131I-
A110-1 (total volume 200 l). To measure VCAM-1 expression, mice
were injected with 10 g 125I- 5F10, 20 g unlabeled 5F10, and
400,000–600,000 cpm of 131I-P-23 (total volume 200 l). The Abs
were allowed to circulate for 5 min, after which the animals were
immediately heparinized (40 U) and rapidly exsanguinated using
bicarbonate-buffered saline. Organs of interest were harvested and
weighed, and 131I and 125I levels were measured in plasma and
tissue samples. Relative P-selectin and VCAM-1 expression levels
were calculated by subtracting the accumulated activity of the non-
specific Ab (131I) from the accumulated activity of the blocking mAb
(125I). Adhesion molecule data are given as the percentage of the
injected dose of Ab per gram of tissue.
Enzyme Assays
The effect of anti-mouse VAP-1 antibodies on the enzymatic activ-
ity of VAP-1 was measured both in vitro and in vivo. For in vitro
assays, CHO cells stably transfected with mouse VAP-1 cDNA and
preincubated with two control mAbs (Hermes-1 against CD44 and
TK8-18 against human VAP-1), with anti-mouseVAP-1 mAbs (7-88,
7-106, and 7-188; each at 10 g/ml and at 50 g/ml), or left without
pretreatments. Following treatment with 1 mM semicarbazide (a
VAP-1 enzyme inhibitor) and VAP-1 substrate (1 mM benzylamine),
the formation of hydrogen peroxide (an end product of the reaction
catalyzed by VAP-1) was measured using fluorometric Amplex Red
assay, as described (Salmi et al., 2001). The specific activity of
VAP-1 was determined by subtracting the amount of H2O2 formed
in the presence of semicarbazide from the amount of H2O2 formed
without the semicarbazide pretreatment and expressed as pmol/
hr/well.
For the in vivo analyses, 200 g anti-VAP-1 and control mAbs (in
the case of anti-VAP-1 pool, each of the three mAbs was at 100
g/ml) were administered intravenously to mice. The serum was
then collected and used as the first-stage reagent in immunohisto-
chemical stainings of wild-type mouse tissues. The VAP-1 enzyme
activity in the serum (soluble VAP-1) was analyzed using the radio-
chemical assay wherein 30 l of serum was incubated in the pres-
ence and absence of 1 mM semicarbazide with [7-14C]benzylamine
(specific activity 57 mCi/mmol) for 2 hr at 37C. The formation of
radiolabeled benzaldehyde (an end product of the reaction cata-
lyzed by VAP-1) was determined using scintillation counting and
expressed as pmol/hr/ml serum, as described (Kurkijarvi et al.,
2000).
Immunohistochemistry
Esterase staining was performed as previously described (Bonder
et al., 2004). Neutrophil numbers were determined by counting the
number of positively stained cells over 20 fields at 40× magnifica-
tion and calculating the average number of positive cells per high-
power field (hpf).
For VAP-1, CD4+, VCAM-1, and MAdCAM-1 staining, mice were
sacrificed, and livers were frozen in OCT compound (Tissue Tek
USA Inc., Torrence, CA). 4–6 m thick sections were stained for
VAP-1 using a cocktail of 7-88, 7-106, and 7-188 (5–10 g each),
CD4 (1:250 dilution), VCAM-1 (1:500 dilution), MAdCAM-1 (1:300
dilution). Biotinylated secondary antibodies were administered fol-
lowed by incubation with peroxidase-labeled ABC avidin biotin
complex and developing with Sigma Fast DAB chromogen solution
(Sigma Chemical Co.). The intensity of staining was scored in a
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Jlinded fashion as follows: (0) negative staining of vessel wall for
AP-1; (1) weak and punctuate staining confined to the vessel wall;
2) moderate and even staining of the vessel with mild diffusion
way from the vessel wall; and (3) strong and even staining of the
essel with intense diffusion of VAP-1 away from the vessel wall
Bono et al., 1999).
tatistical Analysis
ll results are expressed as mean ± standard error (SEM). An un-
aired Student’s t test with a Welch’s correction, where necessary,
as used for comparisons between two means. Analysis of vari-
nce (ANOVA) followed by a Newman-Keul post test was used for
omparisons between more than two means. Statistical signifi-
ance was set at p % 0.05.
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